Menu

Antibodies Prevent HIV Infection in Monkeys

Infusing anti-HIV antibodies provides macaques with protection against infection for up to six months, according to a study.

Apr 29, 2016
Jef Akst

HIV-infected T cellFLICKR, NIAIDWith a successful HIV vaccine still proving elusive, researchers have proposed antibody injections as possible short-term protection against the virus. Previous work has demonstrated that treating mice or macaques with anti-HIV antibodies can protect the animals against subsequent high-dose challenges with HIV or related viruses. Scientists from the National Institute of Allergy and Infectious Diseases (NIAID) and their colleagues have now shown that such protection may last for six months or more. After receiving a single injection of one of four broadly neutralizing HIV antibodies, macaques were able to withstand weekly low-dose challenges of a simian/human (SIV/HIV) chimeric virus for three to six months, according to a study published this week (April 27) in Nature.

“The result is surprising,” Ruth Ruprecht, who directs the AIDS Research Program at Texas Biomedical Research Institute and was not involved in the study, told The Verge. “I am astonished by how long protection lasted.”

“A caveat is that monkeys are not humans, but the model the authors use is about as good as it gets, and the results are a boost to HIV vaccine research and the use of passive antibodies as long-acting preventives,” Scripps Research Institute immunologist Dennis Burton, who was not involved with the work, told Nature. Moreover, added study coauthor Malcolm Martin of NIAID, “this might turn out to be a seasonal alternative to a vaccine until we really know how to make one.”

Such antibody treatments could also one day serve as an alternative to the daily pills of the pre-exposure prophylaxis (PrEP) administered to at-risk individuals today. “PrEP is good if people take it, but we all know that human nature is such that we’re not perfect. We forget things,” Ruprecht told The Verge.

As antibody levels in the monkeys’ blood declined, the animals’ probability of infection following exposure increased. Martin’s team is now working to tweak one of the antibodies so that it will last in the body for a longer period of time. Another way to boost the treatment’s efficacy might be to use a combination of antibodies, the researchers proposed.

“With the extraordinary progress that’s been made just in the past six years, I’m more optimistic than ever that the field will eventually succeed in having an effective prevention measure,” David Montefiori, the director of the Laboratory for AIDS Vaccine Research and Development at Duke University who was not involved in the research, told The Verge. “Hopefully, we’ll see the light at the end of the tunnel within the next 10 years.”

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.
Corning Introduces New 1536-well Spheroid Microplate
Corning Introduces New 1536-well Spheroid Microplate
High-throughput spheroid microplate benefits cancer research, drug screening